Nat. Med. 16, 123–128 (2010); published online 20 December 2010; corrected after print 18 August 2016
In the version of this article initially published, the article did not mention some restrictions on the availability of reagents. Please note that the retroviral vectors containing BCL-6 and BCL-xL have been generated by a for-profit company, AIMM Therapeutics, which makes the plasmids available. Obtaining the plasmids requires an MTA (http://www.aimmtherapeutics.com/partnering/academic-collaboration/) that includes financial obligations.
Additional information
The online version of the original article can be found at 10.1038/nm.2071
Rights and permissions
About this article
Cite this article
Kwakkenbos, M., Diehl, S., Yasuda, E. et al. Correction: Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming. Nat Med 22, 1502 (2016). https://doi.org/10.1038/nm1216-1502a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1216-1502a
